Skip to main content

Table 2 Sociodemographic and medical characteristics of 53,963 patients seeking medical cannabis certification from CB2 Insights clinics in five states

From: Comparing medical cannabis use in 5 US states: a retrospective database study

Characteristic

Massachusetts

Colorado

Maine

Connecticut

Maryland

Total

n = 27,892

mean (SD) or n (%)

n = 16,434

mean (SD) or n (%)

n = 4591

mean (SD) or n (%)

n = 2643

mean (SD) or n (%)

n = 2403

mean (SD) or n (%)

n = 61,379

mean (SD) or %

Age (years), mean (SD)a,b

47.0 (15.9)

43.3 (15.9)

46.2 (15.6)

42.2 (14.4)

45.7 (15.7)

45.5 (15.8)

Gender

 Male

14,615 (52.4%)

9,969 (60.7%)

2,720 (59.2%)

1,506 (57.0%)

1,019 (42.4%)

54.8%

 Female

10,413 (37.3%)

6,353 (38.7%)

1,746 (38.0%)

1,067 (40.4%)

714 (29.7%)

37.8%

 Non-binary

12 (0.0%)

5 (0.0%)

1 (0.0%)

6 (0.2%)

4 (0.2%)

0.1%

 Unknown/unspecified

2,851 (10.2%)

107 (0.7%)

124 (2.7%)

64 (2.4%)

666 (27.7%)

7.3%

Race

n=11,005

n=12,266

n=1,452

n=1,927

n=654

n=32,275

 White

10,304 (93.6%)

10,372 (84.6%)

1,396 (96.1%)

1,615 (83.8%)

446 (68.2%)

87.5%

 Black

451 (4.1%)

1,169 (9.5%)

17 (1.2%)

268 (13.9%)

184 (28.1%)

8.5%

 Other

110 (1.0%)

316 (2.6%)

20 (1.4%)

21 (1.1%)

6 (0.9%)

1.6%

 Asian

94 (0.9%)

117 (1.0%)

7 (0.5%)

13 (0.7%)

10 (1.5%)

0.9%

 American Indian/Alaska Native

9 (0.1%)

210 (1.7%)

10 (0.7%)

6 (0.3%)

2 (0.3%)

0.8%

 Middle Eastern

22 (0.2%)

19 (0.2%)

0 (0.0%)

3 (0.2%)

3 (0.5%)

0.2%

 Native Hawaiian/other Pacific Islander

2 (0.0%)

47 (0.4%)

2 (0.1%)

0 (0.0%)

2 (0.3%)

0.2%

 South East Asian

13 (0.1%)

16 (0.1%)

0 (0.0%)

1 (0.1%)

1 (0.2%)

0.1%

Surrogate household income

n=25,182

n=15,627

n=4,222

n=2,595

n=1,718

n=56,083

 Median

$75,480

$64,251

$55,737

$71,961

$84,257

$69,481

 (IQR)

($37,785)

($32,120)

($19,633)

($29,852)

($37,917)

($35,807)

Smoking statusa,b

 Smoker

3,994 (14.3%)

4,059 (24.7%)

1,022 (22.3%)

638 (24.1%)

271 (11.3%)

18.8%

 Non-Smoker

23,897 (85.7%)

12,375 (75.3%)

3,569 (77.7%)

2,005 (75.9%)

2,132 (88.7%)

81.2%

Alcohol consumptiona,b

 Yes

12,459 (44.7%)

6,323 (38.5%)

1,905 (41.5%)

1,081 (40.9%)

976 (40.6%)

42.5%

 No

15,432 (55.3%)

10,111 (61.5%)

2,686 (58.5%)

1,562 (59.1%)

1,427 (59.4%)

57.5%

Previous cannabis experiencea,b

 Yes

20,118 (72.1%)

10,450 (63.6%)

3,509 (76.4%)

1,959 (74.1%)

1,399 (58.2%)

66.9%

 No

7,773 (27.9%)

5,984 (36.4%)

1,082 (23.6%)

684 (25.9%)

1,004 (41.8%)

33.1%

Use of non-cannabis illicit drugs

 Yes

95 (0.3%)

89 (0.5%)

15 (0.3%)

12 (0.5%)

5 (0.2%)

0.4%

 No

27,796 (99.7%)

16,345 (99.5%)

4,576 (99.7%)

2,631 (99.5%)

2,398 (99.8%)

99.6%

History of substance abusea,b

 Yes

1,875 (6.7%)

380 (2.3%)

296 (6.4%)

330 (12.5%)

81 (3.4%)

5.6%

 No

26.016 (93.3%)

16,054 (97.7%)

4,295 (93.6%)

2,313 (87.5%)

2,322 (96.6%)

94.4%

Number of medicationsa,b

 0

14,272 (51.2%)

11,233 (68.4%)

2,625 (57.2%)

1,252 (47.4%)

1,216 (50.6%)

55.8%

 1

3,780 (13.6%)

1,601 (9.7%)

569 (12.4%)

358 (13.5%)

427 (17.8%)

12.8%

 2

2,263 (8.1%)

956 (5.8%)

399 (8.7%)

210 (8.0%)

226 (9.4%)

7.7%

 3

1,683 (6.0%)

738 (4.5%)

244 (5.3%)

179 (6.8%)

158 (6.6%)

5.7%

 4

1,115 (4.0%)

515 (3.1%)

167 (3.6%)

120 (4.5%)

124 (5.1%)

3.9%

 5+

4,779 (17.1%)

1,391 (8.5%)

587 (12.8%)

524 (19.8%)

252 (10.5%)

14.0%

Average number of medications

2.2 (3.5)

1.2 (2.5)

1.7 (3.1)

2.5 (3.7)

1.7 (2.8)

2.1 (4.8)

Number of non-pharmacologic therapies used

 0

10,408 (37.3%)

7,979 (48.6%)

1,570 (34.2%)

997 (37.7%)

1,065 (44.3%)

40.6%

 1

5,558 (19.9%)

3,537 (21.5%)

1,121 (24.4%)

586 (22.2%)

487 (20.3%)

20.9%

 2

4,461 (16.0%)

2,256 (13.7%)

789 (17.2%)

388 (14.7%)

322 (13.4%)

15.3%

 3

3,184 (11.4%)

1,264 (7.7%)

503 (11.0%)

265 (10.0%)

264 (11.0%)

10.1%

 4

1,904 (6.9%)

674 (4.1%)

273 (5.9%)

181 (6.8%)

148 (6.2%)

6.0%

 5+

2,377 (8.5%)

724 (4.4%)

335 (7.3%)

226 (8.6%)

117 (4.9%)

7.1%

Non-pharmacologic therapies

 Exercise

12,540 (45.0%)

5,935 (36.1%)

2,151 (46.9%)

1,137 (43.0%)

935 (38.9%)

42.1%

 Massage therapy

6,750 (24.2%)

2,937 (17.9%)

972 (21.2%)

511 (19.3%)

466 (19.4%)

21.6%

 Chiropractor

5,540 (19.9%)

2,272 (13.8%)

1,050 (22.9%)

362 (13.7%)

349 (14.5%)

18.0%

 Mental health counselling

6,117 (21.9%)

1,579 (9.6%)

864 (18.8%)

757 (28.6%)

421 (17.5%)

18.3%

 Physiotherapy

1,342 (4.8%)

1,270 (7.7%)

215 (4.7%)

102 (3.9%)

100 (4.2%)

5.5%

 Mindfulness-based cognitive therapy

2,760 (9.9%)

1,111 (6.8%)

251 (5.5%)

295 (11.2%)

175 (7.3%)

8.4%

 Aromatherapy

1,669 (6.0%)

1,015 (6.2%)

293 (6.4%)

211 (8.0%)

139 (5.8%)

6.3%

 Homeopathic medicine

1,467 (5.3%)

793 (4.8%)

278 (6.1%)

123 (4.7%)

92 (3.8%)

5.2%

 Acupuncture

3,309 (11.9%)

769 (4.7%)

503 (11.0%)

206 (7.8%)

243 (10.1%)

9.2%

 Cognitive behavioural therapy (CBT)

1,885 (6.8%)

478 (2.9%)

270 (5.9%)

213 (8.1%)

115 (4.8%)

5.7%

 Naturopathic medicine

860 (3.1%)

403 (2.5%)

149 (3.2%)

104 (3.9%)

49 (2.0%)

2.9%

 Reiki

1,380 (4.9%)

308 (1.9%)

205 (4.5%)

113 (4.3%)

71 (3.0%)

3.8%

 Addictions counselling

602 (2.2%)

137 (0.8%)

131 (2.9%)

115 (4.4%)

35 (1.5%)

1.9%

 Acudetox

19 (0.1%)

29 (0.2%)

7 (0.2%)

4 (0.2%)

6 (0.2%)

0.1%

 Other

42 (0.1%)

11 (0.1%)

18 (0.4%)

8 (0.3%)

8 (0.3%)

0.4%

Number of comorbid conditions

 0

2,206 (7.9%)

6,263 (38.1%)

294 (6.4%)

212 (8.0%)

213 (8.9%)

17.6%

 1

5,719 (20.5%)

5,548 (33.8%)

940 (20.5%)

429 (16.2%)

663 (27.6%)

26.0%

 2

4,935 (17.7%)

2,540 (15.5%)

991 (21.6%)

402 (15.2%)

459 (19.1%)

16.1%

 3

4,028 (14.4%)

1,183 (7.2%)

700 (15.2%)

370 (14.0%)

415 (17.3%)

11.9%

 4

3,276 (11.8%)

548 (3.3%)

531 (11.6%)

310 (11.7%)

253 (10.5%)

9.0%

 5+

7,728 (27.7%)

352 (2.1%)

1,135 (24.7%)

920 (34.9%)

400 (16.6%)

19.4%

Total number of conditions, mean (SD)a,b

4.3 (2.8)

2.1 (1.3)

4.1 (2.6)

4.8 (3.1)

3.6 (2.1)

3.7 (2.6)

  1. Table 2 summarizes key patient characteristics of patients seeking medical cannabis access at CB2 Insights clinics between November 2018 and March 2020 across five states. The total column includes all 61,379 patients included in the initial study for comparison, including patients from 12 states (Mahabir et al. 2020). Total number of conditions refers to a count of the number of comorbid conditions plus one for the patients’ primary condition. SD = standard deviation
  2. aIndicates that statistical test for significance was completed between the five states; the total numbers were not included in statistical tests. ANOVA was conducted for average age and average number of conditions between states. Chi-squared tests were conducted for differences in proportions between states
  3. bIndicates that statistical test was significant, and the characteristic was significantly different between states